Literature DB >> 25610231

Relationship of serum paraoxonase enzyme activity and thermal burn injury.

Serap Yildirim1, Songul Doganay1, Abdulkadir Yildirim2, Osman Enver Aydin3, Akar Karakoc2, Esra Laloglu2.   

Abstract

OBJECTIVE: This study investigated changes in serum oxidative stress parameters in burn cases compared to healthy controls.
MATERIALS AND METHODS: This study was performed in 41 burn patients with mild to severe thermal burn injuries and 38 healthy volunteers. The burn cases were selected from patients who were hospitalized in the burn unit for the treatment of second- and third-degree burns. Malondialdehyde (MDA) levels and PON-1 paraoxonase and arylesterase activities were measured in patient serum samples.
RESULTS: PON-1 paraoxonase activity and MDA levels in patients with major thermal burn injury were significantly higher than healthy controls, but PON-1 arylesterase activities were lower. A significant negative correlation was observed between the burn percentage of the total body surface area and the PON-1 arylesterase activities in patients.
CONCLUSION: Human thermal burn injury was associated with an increase in MDA production and a decrease in PON-1 arylesterase activity, which was proportional to the percentage of total burned surface area.

Entities:  

Keywords:  Arylesterase; Malondialdehyde; Oxidative stress; Paraoxonase; Thermal burn

Year:  2012        PMID: 25610231      PMCID: PMC4261377          DOI: 10.5152/eajm.2012.36

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  17 in total

1.  Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.

Authors:  Serap Yıldırım; Sedat Akar; Mutlu Kuyucu; Abdulkadir Yıldırım; Senol Dane; Recep Aygül
Journal:  Cell Biochem Funct       Date:  2011-07-14       Impact factor: 3.685

2.  Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.

Authors:  No Soo Kim; Byoung Kab Kang; Min Ho Cha; Se-Mi Oh; Mi Mi Ko; Ok-Sun Bang
Journal:  Clin Biochem       Date:  2009-02-20       Impact factor: 3.281

3.  Cardiac mitochondrial damage and loss of ROS defense after burn injury: the beneficial effects of antioxidant therapy.

Authors:  Qun Zang; David L Maass; Jean White; Jureta W Horton
Journal:  J Appl Physiol (1985)       Date:  2006-08-24

Review 4.  Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.

Authors:  Dejan Milatovic; Michael Aschner
Journal:  Curr Protoc Toxicol       Date:  2009-02

5.  The effects of dexmedetomidine on ischemia reperfusion injury in patients undergoing arthroscopy under spinal anesthesia.

Authors:  Senem Koruk; Ayse Mizrak; Recai Kaya; Berna Ugur; Oguz Cebesoy; Ahmet Celik; Unsal Oner
Journal:  Eurasian J Med       Date:  2010-12

6.  Paraoxonase and arylesterase activities in patients with preeclampsia.

Authors:  Ayse Nur Aksoy; Nurinnisa Ozturk; Hulya Aksoy; Fatih Akcay
Journal:  Eurasian J Med       Date:  2008-04

7.  The effect of dehydroepiandrosterone on renal ischemia-reperfusion-induced oxidative stress in rabbits.

Authors:  Yilmaz Aksoy; Turgut Yapanoglu; Hülya Aksou; A Kadir Yildirim
Journal:  Urol Res       Date:  2004-05

Review 8.  Oxidative stress and anti-oxidative mobilization in burn injury.

Authors:  Arti Parihar; Mordhwaj S Parihar; Stephen Milner; Satyanarayan Bhat
Journal:  Burns       Date:  2007-10-01       Impact factor: 2.744

Review 9.  Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy.

Authors:  Jureta W Horton
Journal:  Toxicology       Date:  2003-07-15       Impact factor: 4.221

10.  Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.

Authors:  Kazuo Sonoki; Masanori Iwase; Nobuhiro Sasaki; Shigehiro Ohdo; Shun Higuchi; Naoto Matsuyama; Mitsuo Iida
Journal:  Diabetes Res Clin Pract       Date:  2009-09-11       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.